期刊文献+

Bostrycin作为肺癌分子靶向药物的体外研究

In vitro study of Bostrycin as a molecule target drug in lung cancer
原文传递
导出
摘要 目的观察海洋真菌新结构先导化合物Bostrycin对A549细胞增殖和凋亡的影响,并探讨其作用机制。方法A549细胞完全随机分为实验组和对照组,实验组用不同浓度不同作用时间的Bostzycin进行处理,而对照组未经Bostrycin处理。用MTT法检测A549细胞增殖率的变化;电镜、流式细胞术检测凋亡;实时定量PCR和免疫印迹法探讨其作用机制。结果Bostrycin浓度≥10μmol/L时对A549细胞增殖有明显的抑制作用,其24、48和72h的半数抑制浓度(IC50)分别为20,20、14.36和9.42μmol/L。Bostrycin干预后,电镜观察到A549细胞典型的凋亡形态;流式细胞术结果显示其G0/G1期比例升高、S期和G2/M期比例下降,凋亡率增加。实时定量PCR检测到微小RNA(miRNA)-638和miRNA-923的表达较对照组上调。免疫印迹结果显示p110ix、p-Akt蛋白表达量下降,p27蛋白表达量升高。结论Bostrycin对A549细胞增殖有显著抑制作用,该作用可能通过miRNA抑制磷脂酰肌醇3-激酶/蛋白激酶B(P13K/Akt)通路进行。 Objective To investigate the effect of the new-structure compound Bostrycin from marine fungi on the proliferation and apoptosis of lung cancer cell A549 in vitro, and to explore its mechanism. Methods A549 cells were complete randomly divided into treatment group and control group. A549 cells in treatment group were treated with different concentrations of Bostrycin for different time while cells in control group were not. The rate of proliferation of A549 cells before and after treatment was assessed with MTT method, Electron microscopy and flow cytometry were used to detect apoptosis of the cells. Real time PCR and Western blot were employed to explore the mechanism of Bostrycin. Results Bostrycin at a level of ≥ 10 μmol/L had a significant inhibitory effect on the proliferation of A549 cell, and the 24-, 48- and 72-hour ICs0 (inhibitory concentration of half) were 20.20, 14.36 and 9.42 μ mol/L, respectively. Following Bostrycin interference, typical apoptotic appearance of A549 ceils could be observed under electron microscope. Percentage increased for the cells at G0/G1 phase and decreased for the cells at S phase or G2/M phase with increased apoptotic rate as were revealed by flow cytometry. Signal up-regulation was detected with real time RT-PCR in both micro RNA-638 and micro RNA-923, and decreased expression of the proteins p110 α and p- Akt and increased expression of p27 protein were found by Western blot. Conclusions Bostrycin has significant inhibition on A549 cell proliferation possibly through suppression of PI3K/Akt pathway by micro RNAs.
出处 《中华生物医学工程杂志》 CAS 2009年第6期421-426,共6页 Chinese Journal of Biomedical Engineering
基金 广东省自然科学基金(7001646) 广东省科技计划项目(20088080703022)
关键词 肺癌 药理作用机制 抗肿瘤药 磷脂酰肌醇3-激酶/蛋白激酶B A549细胞 Lung cancer Pharmacological mechanisms of action Antineoplastic agents Phosphatidylinositol 3 kinase/protein kinase B A549 cells
  • 相关文献

参考文献24

  • 1Mayer AM, Gustafson KR. Marine pharmacology in 2005-2006: antitumour and cytotoxie compounds. Eur J Cancer, 2008, 44: 2357-2387.
  • 2Hemstrom TH, Sandstrom M, Zhivotovsky B. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells. Int J Cancer, 2006, 119: 1028-1038.
  • 3Sun SY, Zhou Z, Wang R, et al. The farnesyltransferase inhibitor Lonafarnib induces growth arrest or apoptosis of human lung cancer ceils without downregulation of Akt. Cancer Biol Ther, 200d, 3: 1092-1101.
  • 4Nana-Sinkam SP, Geraci MW. MicroRNA in lung cancer. J Thorac Oncol, 2006, 1: 929-931.
  • 5Yanalhara N, Caplen N, Bowman E, el al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9: 189-198.
  • 6Kumar MS, Erkeland SJ, Pester RE, et al. Suppression of nonsmall cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA, 2008, 105: 3903-3908.
  • 7Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun, 2008, 373: 607-612.
  • 8Yu SL, Chen HY, Chang GC, et al. MieroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 2008, 13: 48-57.
  • 9Markou A, Tsaroucha EG, Kaklamanis L, et al. Prognostic value of mature microRNA - 21 and microRNA - 205 overexpression in non-small cell lung cancer by quantitative realtime RT-PCR. Clin Chem, 2008, 54: 1696-1704.
  • 10Weiss GJ, Bemis LT, Nakajima E, et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol, 2008, 19: 1053-1059.

二级参考文献16

  • 1王岳松 胡益云 罗志红.p27及bcl—2在人非小细胞肺癌组织中的表达及临床意义[J].中华结核和呼吸杂志,2000,23(9):530-530.
  • 2Yokozawa T,Towatari M,Lida H,et al.Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia[J].Leukemia,2000,14(1):28-33.
  • 3Chiarle R,Budel L M,Skolink J.Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma[J].Blood,2000,95(2):619-626.
  • 4Motti M L,Califano D,Troncone G,et al.Complex regulation of the cyclin-dependent kinase inhibitor p27kipl in thyroid cancer cells by the PI3K/AKT pathway:regulation of p27kip1 expression and localization[J].Am J Pathol,2005,166(3):737-749.
  • 5Jiang Y,Zhao R C,Verfaillie C M.Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34 + cell proliferation:BCR/ABL up-regulates the cyclin-dependent kinase inhibitor,p27Kip,which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity[J].Proc Natl Acad Sci USA,2000,97(19):10538-10543.
  • 6Singh S P,Lipman J,Goldman H,et al.Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma[J].Cancer Res,1998,58(8):1730-1735.
  • 7Lee S H,Kim H S,Park W S,et al.Non-small cell lung cancers frequently express phosphorylated Akt;an immunohistochemical study[J].APMIS,2002,110(7-8):587-592.
  • 8Rodier G,Montagnoli A,Di Marcotullio L,et al.P27 cytoplasmic localization is regulated by phosphorylation on Serl0 and is not a prerequisite for its proteolysis[J].EMBO J,2001,20 (23):6672-6682.
  • 9Viglietto G,Motti M L,Bruni P,et al.Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kipl) by PKB/Akt-mediated phosphorylation in breast cancer[J].Nat Med,2002,8(10):1136-1144.
  • 10Orend G,Hunter T,Ruoslahti E.Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorageindependent cells[J].Oncogene,1998,16(20):2575-2583.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部